Medtronic EVP & RTG President Geoffrey S. Martha To Speak At Cowen and Company Healthcare Conference
DUBLIN - Feb. 27, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual Cowen and Company Healthcare Conference on Tuesday, March 7, 2017, in Boston, Mass.
Geoff Martha, executive vice president and president of the Medtronic Restorative Therapies Group (RTG), will answer questions about the company beginning at 8:40 a.m. EST (7:40 a.m. CST).
A live audio webcast of the presentation will be available on March 7, 2017, by clicking on the Investor Events link at http://investorrelations.medtronic.com. An archive of the session will be available on the same webpage later in the day.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Geoff Martha, executive vice president and president of the Medtronic Restorative Therapies Group (RTG), will answer questions about the company beginning at 8:40 a.m. EST (7:40 a.m. CST).
A live audio webcast of the presentation will be available on March 7, 2017, by clicking on the Investor Events link at http://investorrelations.medtronic.com. An archive of the session will be available on the same webpage later in the day.
About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 88,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.